Tyra Biosciences (TYRA) Interest Expenses (2020 - 2026)
Tyra Biosciences (TYRA) posted Interest Expenses of $324.4 million for Q1 2026, up 162116.5% on a QoQ basis from $200000.0 in Q4 2025, and up 2309.45% year-over-year from $13.5 million in Q1 2025.
Tyra Biosciences (TYRA) Interest Expenses (2020 - 2026) Analysis & Trends
Tyra Biosciences' Interest Expenses history runs 7 years deep, the most recent figure standing at $324.4 million for Q1 2026.
- Quarterly Interest Expenses rose 2309.45% year-over-year to $324.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $324.4 million (up 2309.45% YoY) and the FY2025 annual result came in at $186.7 million, up 452.31% from the prior year.
- Interest Expenses was $324.4 million for Q1 2026 at Tyra Biosciences, up from $200000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $324.4 million in Q1 2026 and bottomed at $90000.0 in Q2 2022.
- A 5-year average of $50.5 million and a median of $30.0 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses soared 63605.56% — and 2025, when it slumped 76.31%.
- Tyra Biosciences' Interest Expenses stood at $100000.0 in 2022, then surged by 39878.0% to $40.0 million in 2023, then plunged by 99.25% to $300000.0 in 2024, then slumped by 33.33% to $200000.0 in 2025, then jumped by 162116.5% to $324.4 million in 2026.
- Business Quant data shows TYRA's Interest Expenses at $324.4 million in Q1 2026, $200000.0 in Q4 2025, and $46.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Tyra Biosciences | 1.90 Bn | 1.90 Bn | - | 324.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 324.43 Mn |
| Mar 31, 2026 | 324.43 Mn |
| Dec 31, 2025 | 200,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 46.02 Mn |
| Sep 30, 2025 | 46.02 Mn |
| Jun 30, 2025 | 13.80 Mn |
| Jun 30, 2025 | 13.80 Mn |
| Mar 31, 2025 | 13.47 Mn |
| Mar 31, 2025 | 13.47 Mn |
| Dec 31, 2024 | 300,000.00 |
| Dec 31, 2024 | 300,000.00 |
| Sep 30, 2024 | 111.00 Mn |
| Sep 30, 2024 | 111.00 Mn |
| Jun 30, 2024 | 50.37 Mn |
| Jun 30, 2024 | 50.37 Mn |
| Mar 31, 2024 | 56.84 Mn |
| Mar 31, 2024 | 56.84 Mn |
| Sep 30, 2023 | 39.98 Mn |
| Sep 30, 2023 | 39.98 Mn |